Bill Text: FL S1300 | 2010 | Regular Session | Comm Sub
Bill Title: Prostate Cancer Awareness Program [SPSC]
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: (Failed) 2010-04-30 - Died in Committee on Higher Education [S1300 Detail]
Download: Florida-2010-S1300-Comm_Sub.html
Florida Senate - 2010 CS for SB 1300 By the Committee on Health Regulation; and Senators Hill, Smith, Siplin, and Fasano 588-04372-10 20101300c1 1 A bill to be entitled 2 An act relating to the Prostate Cancer Awareness 3 Program; amending s. 381.911, F.S.; revising the 4 purpose, structure, and objectives of the Prostate 5 Cancer Awareness Program within the University of 6 Florida Prostate Disease Center; authorizing the 7 University of Florida Prostate Disease Center to work 8 with other organizations and institutions to create a 9 systemic focus on increasing community education and 10 awareness of prostate cancer; requiring the University 11 of Florida Prostate Disease Center to collaborate with 12 the Department of Health to establish the UFPDC 13 Prostate Cancer Task Force, which was formerly 14 designated as a “committee”; requiring the State 15 Surgeon General, upon recommendation of the executive 16 director of the University of Florida Prostate Disease 17 Center in consultation with the Comprehensive Cancer 18 Control Program within the Department of Health and 19 the Florida Cancer Control Program, to appoint members 20 to the UFPDC Prostate Cancer Task Force; providing for 21 reimbursement for per diem and travel expenses; 22 providing for terms of office; providing for the 23 appointment of a chair and co-chair; providing for 24 meetings; providing for a quorum of the task force; 25 providing the duties of the task force, including an 26 annual prostate cancer symposium and submission of an 27 annual report to the Governor, the State Surgeon 28 General, and the Legislature; providing an effective 29 date. 30 31 WHEREAS, the Legislature recognizes that prostate cancer is 32 a major public health problem and that promoting awareness of 33 this disease is in the public interest of this state, and 34 WHEREAS, according to the Department of Health’s Florida 35 Cancer Plan 2003-2006, prostate cancer was the most commonly 36 diagnosed cancer in Florida, accounting for one in every four 37 cancer diagnoses, and 38 WHEREAS, the costs of screening, staging, and treating 39 prostate cancer patients in both dollars and morbidity continue 40 to rise, which threatens the foundation of this state’s health 41 system, and 42 WHEREAS, because African-American men are 2.8 times more 43 likely to succumb to prostate cancer than their white 44 counterparts, a call for action is mandatory, and 45 WHEREAS, there are currently no organized, active, or 46 effective mechanisms in Florida to mitigate the incidence of 47 prostate cancer, the lack of community education and awareness, 48 the racial and ethnic disparities, and rising burdens of 49 prostate cancer, and 50 WHEREAS, the Legislature finds that it is a public 51 necessity to work with the University of Florida Prostate 52 Disease Center to establish the UFPDC Prostate Cancer Task Force 53 and to make changes to the Prostate Cancer Awareness Program in 54 order to more effectively serve the needs of the people in 55 Florida, NOW, THEREFORE, 56 57 Be It Enacted by the Legislature of the State of Florida: 58 59 Section 1. Section 381.911, Florida Statutes, is amended to 60 read: 61 381.911 Prostate Cancer Awareness Program.— 62 (1) To the extent that funds are specifically made 63 available for this purpose, the Prostate Cancer Awareness 64 Program is established within the University of Florida Prostate 65 Disease CenterDepartment of Health. The purpose of this program 66 is to diligently work toward implementingimplementthe 67 recommendations fromofJanuary 2000 of the Florida Prostate 68 Cancer Task Force to provide for statewide outreach to promote 69 prostate cancer awareness, to communicate the advantages of 70 early detection, to report recent progress in prostate cancer 71 research and the availability of clinical trials, to minimize 72 health disparities through outreach, education, and screening 73 events, to communicate best-practice principles to physicians 74 involved in the care of prostate cancer patients, and to 75 establish a communication platform for patients and their 76 advocatesand health education activities to ensure that men are77aware of and appropriately seek medical counseling for prostate78cancer as an early-detection health care measure. 79 (2) For purposes of implementing the program, the 80 University of Florida Prostate Disease Center (UFPDC) may work 81 with other organizations and institutions to create a systemic 82 focus on increasing community education and awareness about 83 prostate cancer byDepartment of Health and the Florida Public84Health Institute, Inc.,may: 85 (a) ConductingConductactivities directly or entering 86enterinto contractsa contractwithaqualified nonprofit 87 community education entitiesentity. 88 (b) SeekingSeekany available gifts, grants, or funds from 89 the state, the Federal Government, philanthropic foundations, 90 and industry or business groups. 91 (3) The University of Florida Prostate Disease Center shall 92 collaborate with the Department of Health to establish the UFPDC 93 Prostate Cancer Task Force and to lead the task force in 94 developing and implementing strategies to improve early 95 detection and, consequently, reduce the number of patients 96 succumbing to prostate cancer.A Prostate Cancer Advisory97committee is created to advise and assist the Department of98Health and the Florida Public Health Institute, Inc., in99implementing the program.100 (a) The State Surgeon General, upon recommendation of the 101 executive director of the University of Florida Prostate Disease 102 Center in consultation with the Comprehensive Cancer Control 103 Program within the Department of Health and the Florida Cancer 104 Control Program, shall appoint geographically and 105 institutionally diverse task forcethe advisorycommittee106 members, who shall consist of: 1071.Three persons from prostate cancer survivor groups or108cancer-related advocacy groups.109 1.2.One personThree personswho is a scientistare110scientistsor cliniciancliniciansfrom a community practice who 111 is a known expert in prostate cancer care, research, or 112 educationpublic universities orresearch organizations. 113 2.3.One personThree personswho isareengaged in the 114 practice of a cancer-related medical specialty from a health 115 organizationorganizationscommitted to cancer research and 116 control. 117 3. The executive director for the University of Florida 118 Prostate Disease Center or his or her designee. 119 4. One person, appointed by the Governor, who is a consumer 120 advocate and has been diagnosed with prostate cancer. 121 5. One person, appointed by the Governor, who is a 122 scientist or clinician from an instate university. 123 6. One person, appointed by the President of the Senate, 124 who is engaged in the practice of a cancer-related medical 125 specialty from a health organization committed to cancer 126 research and control. 127 7. One person from the public, appointed by the President 128 of the Senate, who is a consumer advocate and has been diagnosed 129 with prostate cancer. 130 8. One person, appointed by the Speaker of the House of 131 Representatives, who is a scientist or clinician from a 132 community practice and is a known expert in prostate cancer 133 care, research, or education. 134 9. One person from the public, appointed by the Speaker of 135 the House of Representatives, who is a consumer advocate and has 136 been diagnosed with prostate cancer. 137 138 At least one appointee by the Governor, at least one appointee 139 by the President of the Senate, and at least one appointee by 140 the Speaker of the House of Representatives must be a member of 141 an ethnic or racial minority group. 142 (b) Members shall serve without compensation but are 143 entitled to reimbursement, pursuant to s. 112.061, for per diem 144 and travel expenses incurred in the performance of their 145 official duties. 146 (c) Each member of the task force shall be appointed to a 147 4-year term; however, for the purpose of providing staggered 148 terms, of the initial appointments, four members shall be 149 appointed to 2-year terms and four members shall be appointed to 150 4-year terms with the remaining seat being filled by the UFPDC 151 executive director or his or her designee. 152 (d) At the first meeting of the task force each year, the 153 members shall elect a chair and a vice chair. A vacancy in the 154 office of chair or vice chair shall be filled by vote of the 155 remaining members. The task force shall meet biannually and at 156 other times at the call of the UFPDC executive director or a 157 majority of the task force members. Five of the members of the 158 task force constitute a quorum, and an affirmative vote of a 159 majority of the members present is required for final action. 160 (e) The UFPDC Prostate Cancer Task Force shall: 161 1. Present policy recommendations related to prostate 162 cancer to the Department of Health and other appropriate 163 governmental entities. 164 2. Verify the accuracy of prostate cancer information 165 disseminated to the public. 166 3. Develop effective communication channels among all 167 private and public entities across the state which are involved 168 in prostate cancer education, research, treatment, and patient 169 advocacy. 170 4. Plan, develop, and implement activities designed to 171 heighten awareness and educate residents of this state, 172 especially those residents in underserved areas, regarding the 173 importance of early detection and effective treatment options 174 for prostate cancer. 175 5. Develop effective communication channels to various 176 stakeholders within and across the state. 177 6. Disseminate information on recent progress in prostate 178 cancer research and the availability of clinical trials. 179 7. Minimize health disparities through outreach, education, 180 and early detection initiatives. 181 8. Communicate best-practice principles to physicians 182 involved in the care of patients suffering from prostate cancer. 183 9. Establish a communication platform for patients and 184 their advocates. 185 10. Conduct an annual prostate cancer symposium that brings 186 physicians, researchers, community leaders, prostate cancer 187 survivors, and prostate cancer advocates together to highlight 188 recent advances in prostate cancer research, clinical trials, 189 and best practices in the prevention of the disease, and to 190 promote strategies for successful rural and urban outreach, 191 community education, and increased awareness. 192 11. Submit and present an annual report to the Governor, 193 the President of the Senate, the Speaker of the House of 194 Representatives, and the State Surgeon General by January 15, 195 2011, and by January 15 each following year, which contains 196 recommendations for legislative changes necessary to decrease 197 the incidence of prostate cancer, decrease the racial and ethnic 198 disparities, and promote increased community education and 199 awareness. 200(4)The program shall coordinate its efforts with those of201theFlorida Public Health Institute, Inc.202 Section 2. This act shall take effect July 1, 2010.